Claudia Khayat-Djambas
St Joseph University
Beirut, BA, Lebanon
Beirut, BA, Lebanon
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Pharmacokinetics, Hemostatic Efficacy, and Safety of a New Human Fibrinogen Concentrate in Adult and Pediatric Patients with Congenital Fibrinogen Deficiency.
Journal: Thrombosis and haemostasis
Published: October 17, 2025
Efficacy and Safety of Prophylaxis With a Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease-A WIL-31 Study Sub-Analysis.
Journal: European journal of haematology
Published: August 18, 2025
Factor VIII and von Willebrand factor activity levels during long-term prophylaxis with wilate-Analyses from the WIL-31 study.
Journal: Research and practice in thrombosis and haemostasis
Published: July 03, 2025
Efficacy and safety of plasma-derived von Willebrand factor/factor VIII concentrate (wilate) prophylaxis in children and adolescents with von Willebrand disease - WIL-31 study post hoc analysis.
Journal: Research and practice in thrombosis and haemostasis
Published: January 06, 2025
von Willebrand Factor (VWF) Inhibitors in Two Brothers with von Willebrand Disease: A Case Report.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: December 12, 2024
Extension Study With rVIII-SingleChain in Previously Untreated Patients (PUPs) With Severe Haemophilia A.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: July 02, 2024
Efficacy and Safety of rVIII-SingleChain in Surgical Prophylaxis.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: December 01, 2023
Analysis of fibrinogen concentrate pharmacokinetics and dosing for bleeds and surgery in adults, adolescents, and children with congenital afibrinogenaemia and hypofibrinogenaemia.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 09, 2022
Pediatric M5 acute myeloid leukemia with MLL-SEPT6 fusion and a favorable outcome.
Journal: Leukemia research reports
Published: June 28, 2021
Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients <12 Years of Age with Hemophilia A (SWIFTLY-HA Study).
Journal: Journal of blood medicine
Published: January 06, 2021
Last Updated: 09/26/2026